Publication

Estimated Economic Benefits During The ‘Decade Of Vaccines’ Include Treatment Savings, Gains In Labor Productivity

Authored by:

Stack, M. L., Ozawa, S., Bishai, D. M., et al.

Full Citation:

Stack, M. L., Ozawa, S., Bishai, D. M., et al. 2011. Estimated Economic Benefits During The ‘Decade Of Vaccines’ Include Treatment Savings, Gains In Labor Productivity. Health Affairs. 30(6).

View Publication

Additional key concepts from this publication:

The greatest cost savings from introducing new vaccines and increasing immunization coverage would occur in countries and regions with high disease burden and large populations.

Key Evidence: In a modeled analysis of the economic impact of vaccine use in the world’s 72 poorest countries, for countries included in the analyses from the African region, scaling up coverage of the Rotavirus (RVV) vaccine to 90% was projected to result in more than US$900 million in treatment costs averted.